Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer
LCAT, which is involved in lipid metabolism, is an independent risk factor for liver metastasis following CRC surgery, suggesting its potential as a therapeutic target.
Authors
- Ziqun Li
- Yang Yu (ORCID: https://orcid.org/0000-0002-6455-4649)
- Zhan Yang (ORCID: https://orcid.org/0000-0001-7191-2910)
- Linglong Huang (ORCID: https://orcid.org/0009-0006-9971-7774)
- Shuangshuang Hou
- Jiaqi Wang (ORCID: https://orcid.org/0009-0007-9968-8755)
- Yuyao Wang (ORCID: https://orcid.org/0000-0002-1441-1025)
- Jiajun Yin
- Wu Ju (ORCID: https://orcid.org/0000-0003-4643-9775)
Institutions
- Fuyang Normal University (CN)
- Dalian Medical University (CN)
- Affiliated Zhongshan Hospital of Dalian University (CN)
- Fuyang Second People's Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1186/s12885-025-13882-x
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00